THE SUITABILITY OF THE RESULTS OF CT-SCAN THORAX EXAMINATION WITH CLINICAL SYMPTOMS OF COVID-19 PATIENTS AT KARAWANG HOSPITAL IN 2020-2021 PERIOD Ilma Fiddiyanti (a*), Lukmana Lokarjana (b), Erika Mustika Rahayu (c)
(a) Department of Radiology, Faculty of Medicine, Jenderal Achmad Yani University, Cimahi, Indonesia
*ilmaradiologi[at]gmail.com
(b) Department of Surgery, Faculty of Medicine, Jenderal Achmad Yani University, Cimahi, Indonesia
(c) Doctoral Education Study Program, Faculty of Medicine, Jenderal Achmad Yani University, Cimahi, Indonesia
Abstract
Coronavirus Disease 2019 (COVID-19) is a respiratory disease caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2). Anyone could have asymptomatic to severe symptoms. Radiological examinations, such as X-rays and CT-Scans, are needed. CT-Scan thorax is an examination to assess the progression, severity, and comorbidities based on the consensus of the Radiology Society of North America (RSNA). This study aims to find out the suitability of the results of CT-Scan thorax examination with clinical symptoms of COVID-19 patients at Karawang Hospital in 2020-2021 period. The study used a cross- sectional design with consecutive sampling method. The results of data collection obtained 19 patients, with 13 patients included in inclusion and exclusion criteria. Statistical test using kappa test. The results showed that criteria for age of 50-59 years were 6 people (46.2%) and mostly found in men (61.5%). Moderate-severe symptoms for clinical symptoms criteria in 8 people (61.5%) were found. The characteristics of thorax CT-Scan showed an image of GGO, consolidation, crazy paving pattern, a halo sign in 9 people (69.2%), and thickening of blood vessels in 5 people (38.5%). Based on consensus of RSNA, indeterminate-typical were found in 9 people (69.2%). The results of the kappa test analysis showed conformity with the value of k = 0.675. This research shows the suitability of the results of thorax CT-scan based on RSNA consensus with clinical symptoms of COVID-19.
